IND Safety Letters

Username: HOG_CRA

Password:  (contact Deb Cole if you need help)

IND Safety Report Summary (updated 08/13/2010)**

BY DATE:

• 13AUG2010

• 15JUL2010

• 15JUN2010 

BY DRUG NAME:

• Alimata (pemetrexed) - No INDs*
  • LUN08-137 
• AMG479 - Amgen safety dept distributes INDs to sites directly.
  • LUN08-129  
• Amrubicin (Calsed) (updated 8/13/10)
  • LUN07-130 
• ASA404 (updated 5/17/10)
  • GU09-144
• Aprepitant - No INDs*
  • QL05-37
• Avastin (bevacizumab)  (updated 08/13/10)
  • BRE06-109, COE-02, GU04-75, LUN04-77, LUN05-99, LUN06-116
• BNC-105 - No INDs*
  • GU-145
• Erbitux (cetuximab) (updated 10/07/09)
  • GI05-92, GI05-102, LUN04-79
• Dasatinib (Sprycel) (updated 11/06/09 - IB only)
  • GU07-122, GU07-124
• Enzastaurin (updated 12/04/08)
  • BRE05-97, BRE06-117, LUN06-116
• Lonafarnib (updated 06/15/2010)
  • BRE07-126
• Procrit /Aranesp (epoetin alpha) (updated 09/17/08)
  • No open studies
• RAD001 (everlimus) (updated 08/13/10)
  • GI05-102, GU09-145, GU10-147
• Sutent (sunitinib malate) - No INDs*
  • GI06-112, GU07-123
• Tarceva_(erlotinib) (updated 10/09/08)
  • GI06-101
• Taxol (paclitaxel) - No INDs*
  • GI06-112
• Treanda (bendamustine) (updated 8/13/10)
  • MM08-141
• Zactima (vandetanib) (updated 08/13/10)
  • LUN06-113
• Zometa (zoledronic acid)  (updated 04/14/08)
  • No open studies

* NO INDs: We are in the process of verifying with the drug companies that no INDs are currently available for the listed drug. If there are any necessary INDs for these drugs, we will include these in the monthly IND notification.

 ** PLEASE NOTE: The date indicated in the IND Safety Report Summary is the date on the letter received from the drug company. The file date on the individual IND Safety Reports is the date the report was uploaded to the website and may not correspond to the date in the IND Summary.